- Research works
- 27 ▼ 51% vs 2013–17
- Citations
- 1.3k 50.1 per fractional work
- Top-10% rate
- 8.3% record average 16.5%
- Open access
- 43% world 28%
Not ranked overall: PharmaSeq (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 15.6×. Every wedge is a field page.
Which keywords describe research at PharmaSeq (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Enzyme Regulation, Nucleotide Metabolism, Genetic Variation, Antiretroviral Therapy, HIV Infection, Drug Resistance, Viral Diseases and Integrase Inhibitors.
- Nanoparticles
- Self-Assembly
- Inflammation
- Lab-on-a-Chip
- Hepatitis C Virus
- Liver Disease
- Viral Diseases
- Nucleoside Analogues
- Immune Response
- HIV Infection
- Antiretroviral Therapy
- Nucleotide Metabolism
- Enzyme Regulation
- Genetic Variation
- Drug Resistance
- Epidemiology
- Integrase Inhibitors
- Treatment
- Antiviral Therapy
- Biosensors
- Ribavirin
- Microfluidic Devices
- Point-of-Care Diagnostics
- Machine Learning
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 24 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 24 words, with their numbers
- Enzyme Regulation2▲ 186×1 topic
- Nucleotide Metabolism2▲ 258×1 topic
- Genetic Variation2▲ 25×3 topics
- Antiretroviral Therapy2▲ 32×2 topics
- Drug Resistance2▲ 23×2 topics
- HIV Infection2▲ 61×2 topics
- Epidemiology2▲ 1.78×5 topics
- Immune Response2▲ 11×3 topics
- Integrase Inhibitors2▲ 170×1 topic
- Nucleoside Analogues2▲ 170×1 topic
- Treatment2▲ 5.5×2 topics
- Viral Diseases2▲ 83×2 topics
- Antiviral Therapy2▲ 45×2 topics
- Liver Disease2▲ 50×2 topics
- Biosensors2▲ 11×3 topics
- Hepatitis C Virus2▲ 118×1 topic
- Ribavirin2▲ 118×1 topic
- Lab-on-a-Chip1▲ 35×3 topics
- Microfluidic Devices1▲ 59×2 topics
- Inflammation1▲ 1.95×9 topics
- Point-of-Care Diagnostics1▲ 52×2 topics
- Self-Assembly1▲ 12×2 topics
- Machine Learning1▲ 1.82×5 topics
- Nanoparticles1▲ 3.0×4 topics
Which research topics does PharmaSeq (United States) publish most on?
By volume in 2022–2025: Pharmaceutical studies and practices, Attention Deficit Hyperactivity Disorder, Microbial metabolism and enzyme function and Neuroethics, Human Enhancement, Biomedical Innovations.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
- 2 Attention Deficit Hyperactivity Disorder Psychiatry and Mental health 0 works
- 3 Microbial metabolism and enzyme function Molecular Biology 0 works
- 4 Neuroethics, Human Enhancement, Biomedical Innovations Cognitive Neuroscience 0 works
- 5 Metal-Catalyzed Oxygenation Mechanisms Inorganic Chemistry 0 works
- 6 Network Security and Intrusion Detection Computer Networks and Communications 0 works
- 7 Network Packet Processing and Optimization Hardware and Architecture 0 works
- 8 Pharmacogenetics and Drug Metabolism Pharmacology 0 works
- 9 Internet Traffic Analysis and Secure E-voting Artificial Intelligence 0 works
- 10 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has PharmaSeq (United States)'s research output changed?
Output in 2018–2022 was 51% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Monmouth Junction
- Tris Pharma (United States)
- United Silicon Carbide (United States)
- Knite (United States)
- Provid Pharmaceuticals (United States)
- CytoSorbents (United States)
- Nanonex (United States)
- Diamir (United States)
- Xeme Biopharma (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.